Celularity (CELU) FCF Margin (2020 - 2025)
Celularity's (CELU) quarterly FCF Margin came in at 124.34% in Q4 2025, down 14818.0% year-over-year from N/an in Q4 2024, and down 57.98% quarter-over-quarter from 78.71% in Q3 2025.
Powered by 
Analysis
Celularity (CELU) FCF Margin (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported FCF Margin for 6 consecutive years, with 124.34% the latest figure, recorded in Q4 2025.
- On a quarterly basis, FCF Margin fell 14818.0% year-over-year to 124.34% in Q4 2025; TTM through Dec 2025 was 49.92%, a 2844.0% decrease from a year earlier, with the FY2025 full-year figure at 49.92%, down 3535.0% from the prior year.
- FCF Margin was 124.34% for Q4 2025 at Celularity, down from 78.71% in the prior quarter.
- Over five years, FCF Margin peaked at 23.84% in Q4 2024 and troughed at 999.95% in Q2 2022.
- A 5-year average of 363.01% and a median of 275.41% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 102098 bps in 2021 and sank 61218 bps in 2022, its largest moves.
- Over 5 years, FCF Margin stood at 707.33% in 2021, then retreated by 4 bps to 735.38% in 2022, then soared by 95 bps to 38.28% in 2023, then soared by 162 bps to 23.84% in 2024, then plunged by 622 bps to 124.34% in 2025.
- The last three FCF Margin figures came in at 124.34% (Q4 2025), 78.71% (Q3 2025), and 17.42% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.24 Bn | 9.40 Bn | 112.79 Mn | 59.74% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -826.50% |
| 3 | Iovance Biotherapeutics | 3.67 Bn | 3.37 Bn | 55.72 Mn | -66.71% |
| 4 | Legend Biotech | 3.55 Bn | 2.59 Bn | 251.50 Mn | -3.46% |
| 5 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | -497.31% |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -13,981.63% |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | -33.11% |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 48.98% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 18.67% |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | -124.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -124.34% |
| Sep 30, 2025 | -78.71% |
| Jun 30, 2025 | -17.42% |
| Mar 31, 2025 | -26.19% |
| Dec 31, 2024 | 23.84% |
| Sep 30, 2024 | -1.55% |
| Jun 30, 2024 | -28.73% |
| Mar 31, 2024 | -30.26% |
| Dec 31, 2023 | -38.28% |
| Sep 30, 2023 | -213.00% |
| Jun 30, 2023 | -385.98% |
| Mar 31, 2023 | -398.78% |
| Dec 31, 2022 | -735.38% |
| Sep 30, 2022 | -950.01% |
| Jun 30, 2022 | -999.95% |
| Mar 31, 2022 | -601.63% |
| Dec 31, 2021 | -707.33% |
| Sep 30, 2021 | -337.83% |
| Jun 30, 2021 | -610.20% |
| Mar 31, 2021 | -998.46% |